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Objectives: The relationship between quinolone resistance acquisition and invasion impairment has been studied
in some Salmonella enterica serovars. However, little information has been reported regarding the invasive
human-restricted pathogen Salmonella Typhi. The aim of this study was to investigate the molecular mechan-
isms of quinolone resistance acquisition and its impact on virulence in this serovar.
Methods: Two antibiotic-resistant mutants (Ty_c1 and Ty_c2) were generated from a Salmonella Typhi clinical
isolate (Ty_wt). The three strains were compared in terms of antimicrobial susceptibility, molecular mechanisms
of resistance, gene expression of virulence-related factors, ability to invade eukaryotic cells (human epithelial
cells and macrophages) and cytokine production.
Results: Multidrug resistance in Ty_c2 was attributed to AcrAB/TolC overproduction, decreased OmpF (both
mediated by the mar regulon) and decreased OmpC. The two mutants showed a gradually reduced expression
of virulence-related genes (invA, hilA, hilD, fliC and fimA), correlating with decreasedmotility, reduced infection of
HeLa cells and impaired uptake by and intracellular survival in human macrophages. Moreover, Ty_c2 also
showed reduced tviA expression. Additionally, we revealed a significant reduction in TNF-a and IL-1b production
and decreased NF-kB activation.
Conclusions: In this study, we provide an in-depth characterization of the molecular mechanisms of antibiotic
resistance in the Salmonella Typhi serovar and evidence that acquisition of antimicrobial resistance is concomi-
tantly detected with a loss of virulence (epithelial cell invasion, macrophage phagocytosis and cytokine produc-
tion). We suggest that the low prevalence of clinical isolates of Salmonella Typhi highly resistant to ciprofloxacin is
due to poor immunogenicity and impaired dissemination ability of these isolates.
Introduction
Typhoid fever is a human-restricted systemic infection caused by
Salmonella enterica serovar Typhi. This pathogen causes21 mil-
lion infections causing typhoid fever each year, leading to
200000 deaths.1 The highest incidence rates are seen in Asia,
where this pathogen remains a major public health problem.
The transmission route is through exposure to food and water
contaminated with human faeces. Although it belongs to the
same species as S. enterica serovar Typhimurium, their patho-
genesis substantially differs. While salmonellosis caused by
Salmonella Typhimurium infection is usually self-limiting, typhoid
fever is a systemic infectious disease with muchmore severe con-
sequences. Once bacteria reach the small intestine, they adhere
to the mucosa and mostly invade M cells, which mediate intern-
alization of the pathogen and allow transportation to Peyer’s
patches. This process is followed by phagocytosis by dendritic
cells and macrophages, thus favouring dissemination through
the mesenteric lymph nodes and eventual spread to the liver,
spleen and bonemarrowwhere Salmonella Typhi is able to survive
and replicate.2–4
The treatment of typhoid fever has been changing and adapting
togetherwith the spread of drug-resistant strains. Chloramphenicol,
trimethoprim/sulfamethoxazole and ampicillin were initially
used until the emergence and spread of plasmid-mediated resist-
ance to these antimicrobial agents. As a consequence, these
drugs were replaced by ceftriaxone and ciprofloxacin as well as
other fluoroquinolones such as ofloxacin.5 However, dissemin-
ation in the past decades, mostly in Asia, of strains showing
both resistance to nalidixic acid (MIC .256 mg/L) and decreased
ciprofloxacin susceptibility (DCS) (MIC range, 0.125–1 mg/L) has
occurred.5–7 In addition, some reports have already shown the
Figure Read by: P.L. Copy Edited by: D.T.
# The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved.
For Permissions, please e-mail: journals.permissions@oup.com
J Antimicrob Chemother
doi:10.1093/jac/dkv299
1 of 12
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
105
110
115
emergence of highly fluoroquinolone-resistant isolates.8 – 10
This scenario is forcing the introduction of new-generation fluor-
oquinolones (e.g. gatifloxacin) and alternative drugs such as
azithromycin.5,11
Quinolones act through inhibition of DNA gyrase and topo-
isomerase IV, hampering DNA replication and transcription as
well as interfering with cell division. In S. enterica, resistance to
quinolones is mainly due to point mutations in the quinolone
resistance-determining regions (QRDRs) of the target genes,
with amino acid substitutions at positions 83 and 87 of GyrA
being the most frequently reported.4,12,13 Mutations affecting
the internal accumulation of the drug, by decreasing the expres-
sion of porins (e.g. OmpFand OmpC) and/or increasing the expres-
sion of efflux pumps such as AcrAB/TolC,13–15 are also of great
concern. Expression of the efflux pump AcrAB is controlled by its
local repressor AcrR and by three homologous transcriptional acti-
vators, MarA, SoxS and RamA. The contribution of these regulators
to the MDR phenotype has been reported in laboratory mutants
and clinical isolates in S. enterica.16–20There is only a single excep-
tion, since results concerning the role of MarA have been demon-
strated in Escherichia coli,21 –23 but not yet in clinical isolates of
Salmonella. Similarly, activation of the transcription of micF, an
antisense RNA that inhibits synthesis of the outer membrane
porin OmpF,24 has yet to be supported with clinical data for
Salmonella. In addition, plasmid-encoded genes [e.g. aac(6′)-Ib-cr
and the qnr genes] are also responsible for quinolone resistance in
Salmonella spp.13
Pathogenicity is primarily mediated by a number of virulence
factors, the genes of which are organized within particular regions
of the genome, named Salmonella pathogenicity islands (SPIs). To
date, 15 SPIs have been identified in Salmonella Typhi, among
which SPI-1, homologous to that described in Salmonella
Typhimurium, contains genes encoding the type III secretion
system-1 (T3SS-1) and secreted effector proteins needed for
the invasion process.25–27 Furthermore, Salmonella Typhi-specific
SPI-7 contains genes involved in the biosynthesis, regulation and
export of the Vi capsular antigen. This virulence factor plays a key
role in the attempt of Salmonella Typhi to avoid host defences and
is therefore important in enhancing infectivity and virulence.28
Moreover, innate immune responses such as inflammation are
also activated through the interaction of pathogen-associated
molecular patterns, e.g. LPS and flagellin, with the Toll-like recep-
tors (TLRs) TLR-4 and TLR-5, respectively.4,27,29 Stimulation of
TLRs induces activation of the transcriptional regulator NF-kB,
thus triggering the production of proinflammatory cytokines such
as TNF-a, IL-6 and IL-1b.30
PreviousQ2 reports conducted in non-Typhi S. enterica have
shown that acquisition of quinolone resistance is related to
decreased expression of virulence factors and impaired adher-
ence to and invasion into the host cell.31,32 Even though there is
an epidemiological relatedness between Typhi and non-Typhi ser-
ovars, many differences have been reported in terms of virulence
and colonization behaviour, suggesting that adequate experi-
ments should be conducted to address this relationship in
Salmonella Typhi. Thus, the main objective of this study was to
investigate if this loss of virulence, in terms of invasion and in-
duction of host immune responses, also occurred in Salmonella
Typhi upon acquisition of quinolone resistance. Moreover, despite
the above-mentioned mechanisms of quinolone resistance
being well studied in non-typhoidal Salmonella, an in-depth
characterization of the molecular mechanisms involved in
antibiotic resistance of two Salmonella Typhi mutants was also
carried out.
Materials and methods
Strains
A clinical isolate of Salmonella Typhi was recovered from a patient diag-
nosed with spondylodiscitis at the Hospital Clı´nic of Barcelona (Spain).
This isolate (Ty_wt) was used to generate in vitro antibiotic-resistant
mutants in a multistep selection process, as previously described,31 by
exposure of the bacteria to increasing concentrations of ciprofloxacin,
starting at 0.25 mg/L. The mutants studied in this work were selected at
1 and 2 mg/L ciprofloxacin, named Ty_c1 and Ty_c2, respectively. When Q3
indicated overnight cultures were grown for 16–18 h.
Antimicrobial susceptibility
Antimicrobial susceptibility to nalidixic acid, ciprofloxacin, norfloxacin,
ampicillin, ceftriaxone, cefoxitin, erythromycin, chloramphenicol, tetracyc-
line, trimethoprim and kanamycin was assessed using Etests (bioMe´rieux)
on Mueller–Hinton II plates (Becton Dickinson) following the manufac-
turer’s recommendations. At least three replicates of each susceptibility
test were performed.
Sequencing of quinolone resistance genes
DNA amplification of the target genes gyrA, gyrB, parC and parE as well as
the global regulators acrR,marRAB, soxRS and ramR was performed using
the primers listed in Table S1 (available as Supplementary data at JAC
Online). Sequencing was performed by Beckman Coulter Genomics
(Essex, UK) and the sequences analysed by alignment with the template
sequence of Salmonella Typhi (RefSeq NC 016832.1).
Bacterial growth
Fresh cultures were grown at 378Cwith shaking, as previously described,31
and OD readings at 600 nm (OD600) were done every 15 min for 24 h by
means of an iEMS Multiskan Reader MF (Thermo Fisher Scientific). Each
plate included four replicates of each sample and the assay was repeated
three times.
Motility
Bacterial cultures were grown overnight in LB medium at 378C with shak-
ing and 10 mL was ‘stab inoculated’ into soft agar plates containing 0.5%
agar. Plates were incubated for 7 days at 378C in a humid chamber.
Motility was assessed by measuring and comparing the growth diameter
of the three tested strains.
Relative expression of resistance and virulence genes
RNA extraction from exponential cultures of Ty_wt, Ty_c1 and Ty_c2 was
performed as reported by Fa`brega et al.31 A two-step RT-PCR was per-
formed as previously described by our group33 following the 22DDCT
method. Briefly, the obtained RNA was reverse transcribed to cDNA
using the PrimeScript RT Reagent Kit (Takara) followed by PCR reaction
(SYBRw Premix Ex Taq Tli RNase H Plus Kit, Takara) under universal thermal
cycling conditions. Expression of the efflux-related genes acrB, tolC, emrB
and acrF, the marA regulator, the ompF porin and the virulence-related
genes hilA, hilD, invA, fliC, fimA and tviA was studied. The primers used
(Table S2) were designed using Primer Expressw software (Applied
Biosystems). The 22DDCT method was applied to measure the gene
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expression, defined as relative quantification (RQ) of the target genes in
the twoQ4 mutant strains, normalized with the 16S rRNA as reference
gene and the Ty_wt as calibrator strain. Five independent extractions
were performed and differences of .2-fold were considered relevant.
Standard deviation was calculated and only reported when this value
was .0.1.
Epithelial cell invasion assay
The invasion assay was performed according to Fa`brega et al.31 with some
modifications. Briefly, HeLa cells (ECACC 84211901) were seeded into
6-well tissue culture-treated plates (Corning) in order to obtain a mono-
layer corresponding to5×105 cells/well at 378C in a 5% CO2 atmosphere.
Infection was then performed with bacteria grown overnight at 378Cwith-
out shaking at anmoi of 100. Plateswere incubated at 378C/5%CO2 for 2 h
followed by an additional 2 h of incubation in the presence of 100 mg/L
gentamicin (Life Technologies) to kill extracellular bacteria. Wells were
then washed and 1 mL of chilled sterile water was added and kept at
48C for 30 min to lyse the cells. This volumewas recovered for intracellular
bacterial counting by plating several dilutions in LB agar. At least three
independent experiments were performed with intraexperiment dupli-
cates. The invasion ability of each strain was determined by calculating
the ratio between the number of intracellular bacteria and the inoculum.
Human macrophage infection assay
Human-derived monocytes (U-937 cell line) were used upon differenti-
ation into adherent macrophages with 50 mg/L phorbol 12-myristate
13-acetate. A total of 5×105 cells/well were seeded into 24-well plates
(Becton Dickinson) and incubated at 378C/5% CO2 with RPMI-1640 (Life
Technologies) supplemented with 10% FBS (Life Technologies). After
24 h, wells were washed three times with PBS (Life Technologies) and
new medium was added in order to eliminate the non-adhered cells.
Infection was carried out with Salmonella Typhi strains grown overnight
at 378C without shaking at an moi of 50. Plates were then centrifuged
for 5 min at 2500 g at room temperature and incubated for 20 min at
378C/5% CO2. Afterwards, cells were washed again and newmedium con-
taining 100 mg/L gentamicin was added before incubating for 2 h under
the same conditions as described above. After this time, bacterial entry
into host cells was determined by eliminating the supernatant, incubating
the cells for 15 min at 48Cwith 1 mL of chilled sterile water and then plat-
ing the appropriate dilutions on LB agar plates in order to allow bacterial
counting. Alternatively, to determine the uptake rate, after 2 h of incuba-
tion with 100 mg/L gentamicin, the medium was replaced with new RPMI
containing a lower dose of gentamicin (12 mg/L) andmaintained for 24 h.
Then, wells were washed and treated with 1 mL of chilled sterile water for
cell lysis and bacterial counting. The intracellular survival ability was deter-
mined by calculating the ratio between the number of bacteria recovered
at 24 and 2 h post-infection.
Cytokine assay
Production levels of TNF-a and IL-1b were measured in the supernatants
during the human macrophage infection assay. After the two incubation
periods (2 and 24 h), supernatants were collected and levels of TNF-a
(from the 2 h post-infection plates) and IL-1b (from the 24 h post-
infection plates) weremeasured by ELISA according to themanufacturer’s
recommendations (BD OptEIA).
NF-kB luciferase assay
HEK293 cells stably transfected with an NF-kB luciferase reporter con-
struct, previously obtained by Koblansky et al.,34 were plated onto
48-well plates. After 24 h of incubation at 378C/5% CO2, cells were
stimulated with heat-killed Salmonella Typhi as well as with 0.2 mg/L
TNF-a as a positive control for 6 h. Luciferase activity was measured
with the Luciferase Reporter Assay System (Promega). Heat-killed bacteria
were prepared from an overnight culture adjusted to OD600¼0.7. An
800 mL aliquot of the bacterial culture was centrifuged at 13500 g for
10 min, washed twice with PBS and resuspended in 1 mL of the same
solution. Then, 1 h incubation at 658Cwas followed and the bacterial solu-
tion was vortexed for 3 min and centrifuged for 5 min at 2500 g to discard
protein debris. For stimulation, 25 mL of the supernatant was added to
each well. Each Q5sample was done in triplicate and three independent
assays were performed.
Outer membrane protein analysis
Extraction of outer membrane proteins was performed with N-lauroyl
sarcosinate. Briefly, bacteria were harvested from 200 mL of exponential
culture (OD600¼0.6) by centrifugation at 48C and 3500 g. Cells were
washed twice in PBS in order to remove any residual medium. Then,
cells were resuspended in 6 mL of 10 mM Tris, pH 8.0/1% NaCl. At this
point, cells were sonicated for 15 min (cycles of 59 s ‘on’ and 59 s ‘off’).
After cell disruption, samples were centrifuged at 48C and 3500 g in
order to remove any cell debris. Supernatants were collected and trans-
ferred into ultracentrifugation tubes and samples were centrifuged at
100000 g for 1 h at 48C in a Sorvall MS-150 microultracentrifuge
(Thermo Scientific) using an S50-ST rotor. After this centrifugation step,
the supernatant was discarded and the pellet resuspended in 1% sarcosyl
solution and incubated for 60 min at room temperature with gentle agita-
tion. After incubation, samples were again centrifuged at 100000 g for 1 h
at 48Cand the resulting pelletwas cleaned twicewith 10 mMTris, pH8.0/1%
NaCl. Finally, the pellet was carefully resuspended in 500 mL of milliQ water
and the protein concentration estimated with the 2D-Quant Kit (GE
Healthcare). Protein extracts were separated by SDS–PAGE on 12.5% iso-
cratic Laemmli gels using a mid-size gel casting system (Hoefer SE600
Chroma). Gels were run at 25 mA following themanufacturer’s recommen-
dations. Bands showing differential expression between strains were recov-
ered and further identified through MALDI-TOF MS performed using an
Ultraflex instrument (Bruker Daltonics).
Statistics
Data were analysed using IBM SPSS Statistics 20 software. As data were
normally distributed, multiple comparisons were performed using the
one-way ANOVA test. P values ,0.05 were considered to be significant.
Results
Selection of the strains
A Salmonella Typhi clinical isolate (Ty_wt) was selected to gener-
ate mutants able to grow at inhibitory concentrations of cipro-
floxacin. First, Ty_wt was plated onto MacConkey agar plates
containing 0.25 mg/L ciprofloxacin, corresponding to 0.5× its
MIC (0.5 mg/L). From this point onwards, the concentration of
ciprofloxacin was doubled at each step, in which a single colony
was selected and plated again in the following selection stage,
reaching a ciprofloxacin concentration of 16 mg/L. The mutants
selected for the study were Ty_c1 and Ty_c2, which corresponded
to colonies grown on plates containing 1 and 2 mg/L ciprofloxacin
with MICs of ciprofloxacin of 1 and 8 mg/L, respectively. The
mutant recovered at 4 mg/L ciprofloxacin, with an MIC of 8 mg/L,
was not considered for the study as it showed the same antimicro-
bial susceptibility profile as Ty_c2, suggesting that no additional
resistance mechanisms were selected. Mutants able to grow
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at greater concentrations (8 and 16 mg/L) were also recovered
(MICs 12–24 mg/L), although they could not be further studied
as they showed important growth impairment. Resistant colonies
appeared at frequencies of 2×1026 and 7×1026 mutants per cfu
for Ty_c1 and Ty_c2, respectively. When bacteria were exposed to
a concentration of 8 mg/L ciprofloxacin, theQ6 frequency of selection
decreased to 5.5×1027 and in the presence of 16 mg/L it was
further reduced to 6×1028 mutants per cfu.
To assess reversion of the resistance phenotype, the selected
resistant mutants Ty_c1 and Ty_c2 were plated onto MacConkey
agar plates without antibiotic. However, no revertant colonies
were obtained after 35 consecutive passages.
Bacterial growth
A link between fluoroquinolone resistance and fitness has been
stated previously. Several studies carried out in Salmonella
Typhimurium and S. enterica serovar Enteritidis have shown that
acquisition of high levels of fluoroquinolone resistance have a fit-
ness cost.31,35,36 In order to evaluate this feature in our strains,
bacterial growth was examined. No differences between the
three strains were observed, indicating that acquisition of anti-
microbial resistance in these mutants (ciprofloxacin MICs of 1
and 8 mg/L) did not impose an energy cost on bacterial growth.
However, the mutants with ciprofloxacin MICs of 12 and 32 mg/L
(named Ty_c8 and Ty_c32) showed a much longer lag phase
than the previous strains and Ty_c32 did not reach the same OD
in the stationary phase as the previous mutants (Figure 1).
Moreover, these mutants reached stationary phase (OD600¼0.6)
after 8 h of incubation at 378Cwith shaking, comparedwith 3 h for
Ty_wt, Ty_c1 and Ty_c2. In addition to the altered bacterial
growth, the colonies were phenotypically different from the
others: they were much smaller and did not grow well on
MacConkey agar plates. Taking Q7into account all these observa-
tions, these mutants were excluded from the present study.
Characterization of the antimicrobial resistance
mechanisms
Quinolone resistance profile
The MICs of nalidixic acid and the fluoroquinolones ciprofloxacin
and norfloxacin were determined (Table 1). As Q8expected, the
MICs of the quinolones tested sequentially increased for the two
mutants, except for the MIC of ciprofloxacin for which a slight dif-
ference was recorded between Ty_wt and Ty_c1 whereas the MIC
for Ty_c2 increased 8-fold. In contrast, a 4- and 8-fold increase
was seen for Ty_c1 in the MICs of nalidixic acid (MIC 1000 mg/L)
and norfloxacin (MIC 8 mg/L), respectively, and a further 2- and
3-fold increase for Ty_c2.
In order to study the molecular mechanisms of quinolone
resistance, sequencing of the QRDR of the target genes gyrA,
gyrB, parC and parE was carried out. The results revealed a single
amino acid substitution in GyrA (S83F) in all three strains and
no additional mutations were found in the QRDRs of the mutants.
As mutations outside the QRDR region of gyrA were found in a
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Figure 1. Mutants Ty_c8 and Ty_c32 show impaired growth. Bacterial growth of all the mutants obtained was assessed. The most resistant mutants
(Ty_c8 and Ty_c32) were rejected as they presented growth deficiencies. Results correspond to the mean of three independent experiments.
Table 1. Antimicrobial susceptibility testing of the three strains studied
Strain
MIC (mg/L)
NAL CIP NOR ERY CHL TET TMP AMP FOX CRO KAN
Ty_wt 250 0.5 1 96 4 0.5 0.094 0.094 1 0.064 1
Ty_c1 1000 1 8 128 4 1.5 0.25 0.75 4 0.125 1
Ty_c2 2000 8 24 .256 128 4 0.75 4 128 0.5 1
NAL, nalidixic acid; CIP, ciprofloxacin; NOR, norfloxacin; ERY, erythromycin; CHL, chloramphenicol; TET, tetracycline; TMP, trimethoprim; AMP, ampicillin;
FOX, cefoxitin; CRO, ceftriaxone; KAN, kanamycin.
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previous study and were suggested to contribute to the quinolone
resistance phenotype,37 sequencing of the entire target genes
(gyrA, gyrB, parC and parE) was also performed, but no additional
change was found.
Multidrug resistance profile
The absence of newmutations acquired in the target genes of the
two mutants suggested the acquisition of broad-spectrum resist-
ance mechanisms such as increased efflux. In this context, the
antimicrobial susceptibility profile of Ty_wt, Ty_c1 and Ty_c2
was assessed against a broader collection of antibiotics including
erythromycin, ampicillin, ceftriaxone, cefoxitin, chloramphenicol,
tetracycline, trimethoprim and kanamycin. The results obtained,
reported in Table 1, showed a progressive, but different, increase
in the MIC of most of the antibiotics tested. In comparison with
Ty_wt, Ty_c1 showed the highest increase in the MIC of ampicillin
(8-fold), modest increments (2- to 4-fold) in the MICs of tetracyc-
line, trimethoprim, cefoxitin and ceftriaxone, whereas no major
change (,1.5-fold) was seen for chloramphenicol and erythromy-
cin. Contrarily, a different response was observed for strain Ty_c2.
This mutant could be classified as MDR according to the ECDC.38 It
acquired resistance to cefoxitin and chloramphenicol with a
32-fold increase in the MIC compared with Ty_c1. Moreover, and
even though the MICs of the remaining drugs tested did not reach
the resistance breakpoints, increases of 3- to almost 5-fold were
recorded in all cases. The only antibiotic tested for which no
changes in susceptibility were seen in any of the mutants was
kanamycin.
Efflux and permeability are altered in Ty_c2
In Salmonella Typhimurium, the predominant transport system
involved in multidrug resistance is AcrAB/TolC.15 Other less
frequently detected drug transporters such as AcrF, highly homolo-
gous to AcrB, and EmrB have also been reported to extrude
quinolones13,39 and have been shown to be overexpressed in
quinolone-resistant Salmonella Typhimurium mutants.40 Expression
of the acrB, tolC, acrF, emrB and ompF genes was tested in the
three strains by real-time PCR (RT-PCRQ9 ). Results revealed overex-
pression of acrB and tolC only in Ty_c2 (RQ¼3.91 for acrB and
RQ¼3.42 for tolC). Surprisingly, the other efflux-related genes,
acrF and emrB, were repressed in this strain compared with
Ty_wtQ10 (3- and 3.9-fold, respectively). Additionally, the porin
ompF was .6-fold repressed in Ty_c2. InQ11 the case of Ty_c1, no
major change was detected and considered to be relevant for
any of these genes despite statistically significant differences
were seen for acrF and emrB (fold change,2). Thus, these results
suggest the involvement of AcrAB/TolC and OmpF in themultidrug
resistance profile of Ty_c2 (Table 2).
Analysis of the bacterial outer membrane proteins further con-
firmed part of these changes in gene expression: two bands iden-
tified as AcrA and TolC were overproduced only in Ty_c2, together
with a decreased production of the outer membrane protein
OmpC (Figure 2).
Role of MarA in the antimicrobial resistance profile of Ty_c2
Mutations in AcrR have been shown to impair its repressive effect,
hence leading to derepression of the acrAB genes.16 –18 The Ta
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repressors MarR and RamR and the activator SoxR are regulators
of transcriptional factors MarA, RamA and SoxS, respectively.
Mutations in RamR and SoxR have been reported in different
Salmonella serovars to increase expression of the homologue acti-
vators and, therefore, increase protein levels of AcrAB and down-
regulate OmpF.16–20 However, studies describing mutations in
MarR in strains selected in the clinical setting have been reported
in E. coli, but not in Salmonella spp.21,22
In this study, sequencing of the known regulatory regions of
AcrAB expression (acrR, marRAB, soxRS and ramR) was carried
out. Indeed, an important alteration in the marR locus was
detected in the Ty_c2 mutant corresponding to a deletion of
445 nucleotides. The fragment deleted included the first 411
nucleotides of the marR gene and 34 nucleotides upstream of
the gene (Figure 3). In E. coli, the existence of two binding sites
(Site I and Site II) for MarR in themarO region has been reported.41
In Ty_c2, the entire Site II was deleted although Site I was com-
pletely preserved aswell as the235 and210 elementsQ12 of the pro-
moter. Interpretation of this finding suggests that MarA
expression is not only possible since the promoter is still intact,
but also overexpression is likely to be detected due to a lack of
the MarR protein. Consistently, RT-PCR transcription analysis of
marA revealed high overexpression (RQ 108.19+0.16) in the
MDR strain Ty_c2 compared with Ty_wt and Ty_c1. Nonetheless,
despite no further changes being seen in the sequences of the
other regulators, repression of acrR, soxS and ramA ranging from
2- to almost 6-fold was observed in Ty_c2 (Table 2). The results
obtained in this section suggest that overexpression of MarA is
responsible, at least in part, for the resistance phenotype observed
in Ty_c2.
Evaluation of virulence in the quinolone-resistant
Salmonella Typhi mutants
Gradual reduction of motility seen in Ty_c1 and Ty_c2
Intact motility of Salmonella Typhi has been determined to partici-
pate in the invasion process and is therefore related to the virulence
potential of this pathogen.42,43 For this reason, the motility of the
three strains was measured by inoculation into soft agar plates.
Although the clinical strain (Ty_wt) was already poorly motile,
with a colony diameter of 13 mm, a decrease in motility was
seen for the mutants, showing diameters of 9 mm for Ty_c1 and
7 mm for Ty_c2 (data not shown).
As flagellin is the major component of the bacterial flagellar
filament, the expression profile of the flagellin-encoding gene
fliC was analysed by RT-PCR and revealed statistically significant
differences between the parental strain and the mutants
(Table 2). Ty_c1 showed a 10-fold reduction in fliC expression
levels in comparison with Ty_wt and an additional Q1310-fold
decreased expression was seen for Ty_c2 (RQ¼0.01). These
results are in accordance with the phenotype observed in the
soft agar assay.
In order to determinewhether the differences in fliC expression
could be attributed to the acquisition of mutations within the
gene, fliC as well as the regulators fliA and flhDC, involved in fla-
gella biosynthesis,35,44 were sequenced. Amino acid substitutions
at particular positions of the conserved site of flagellin have been
reported to be essential for protofilament assembly, bacterial
motility and TLR-5 recognition.45 A single mutation in fliC was
found in both Ty_c1 and Ty_c2 leading to the amino acid substitu-
tion T187I whereas no mutations in any of the regulators were
detected. This change detected in the mutants is located outside
of the conserved region, likely suggesting it to be trivial for the
function and structure of flagellin.45
Figure 3. Schematic representation of the deleted region located in the marRAB regulatory region of Ty_c2. The predicted 235 and 210 promoter
regions are shown in underlined bold letters. The two MarR-binding sites (Site I and Site II) are also indicated and extrapolated from E. coli.41 Grey
letters in italics correspond to the deletion detected and numbers in grey indicate the first and last position of the deleted nucleotides.
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Figure 2. Ty_wt, Ty_c1 and Ty_c2 have different outer membrane protein
profiles. Proteins showing differential expression are indicated by arrows.
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Salmonella Typhi mutants are less able to invade
epithelial cells
As described previously in several serovars of S. enterica,31,32,46
acquisition of quinolone resistance has been related to decreased
invasion ability in an in vitro eukaryotic cell model. For this reason,
in vitro invasion of HeLa cells was examined with the three studied
strains (Ty_wt, Ty_c1 and Ty_c2) and revealed a gradual reduction
in the invasion ability of the mutants compared with the parental
isolate. TheQ14 invasion rate of Ty_wt was 7.31%, that of Ty_c1 was
1.69% (4 times lower) and the lowest rate of invasion (0.27%)
was reported for Ty_c2, which was 6 times lower than the Ty_c1
mutant and 27 times lower than Ty_wt (Figure 4a).
Salmonella Typhi mutants show impaired internalization
and survival in macrophages
Internalization of Salmonella Typhi by phagocytes once
Salmonella Typhi has reached the submucosa as well as survival
of the pathogen inside these host cells are crucial processes for
systemic infection.2 Thus, differentiated U-937 human macro-
phages were infected with the three strains. In order to study
their ability to be phagocytosed by macrophages, the number of
intracellular bacteria was determined at 2 h post-infection.
Results were expressed as percentage values of recovered bac-
teria with respect to the total number of infecting bacteria. A
reduction of 2.75-fold in Ty_c1 compared with Ty_wt and an add-
itional 1.6-fold for Ty_c2, which corresponded to 4.37 times less
than Ty_wt, was seen (Figure 4b). Moreover, the intracellular sur-
vival rate was also determined and expressed as the percentage
bacterial count at 2 h versus bacterial load at 24 h post-infection.
Similar results were observed for the two mutants and corre-
sponded to a 4-fold reduction compared with the parental strain
(Figure 4c). These results showed a gradual inability of the
mutants to be recognized bymacrophages and therefore be inter-
nalized. In addition, the internalized bacteriawere less able to sur-
vive inside macrophages, showing no significant differences
between the two mutants.
Transcription levels of virulence factors are low
in Salmonella Typhi mutants
Among the virulence factors reported to play a key role in
Salmonella Typhi–host interactions, several loci have been
described. The invasion process of Salmonella is mainly driven
by virulence determinants contained in SPI-1,25,26,36 such as the
effector invA and the key regulators hilD and hilA.47 Type 1 fim-
briae are important for adhesion to eukaryotic cells and are
encoded by fim genes, with fimA being responsible for the produc-
tion of the major fimbrial subunit.36 The Vi capsular antigen, a
Salmonella Typhi-specific determinant encoded by the tviA gene
located in SPI-7, is involved in systemic dissemination.25 In this
study, the gene expression profiles of invA, hilD, hilA, fimA and
tviAwere evaluated through RT-PCR analysis (Table 2). The results
reflect sequential gene repression in the two mutants compared
with the original strain for almost all the genes tested. In Ty_c1,
invA, hilD, hilA and fimA were 2.5- to 3.75-fold less expressed
than in Ty_wt. On comparing Ty_c2 versus Ty_c1, expression of
these genes was reduced by 1.89- to 3.67-fold. Contrary to the
results observed for these genes, tviA expression in Ty_c1 was
comparable to that seen for the parental strain (RQ¼0.79).
However, almost 30-fold less expression was observed in Ty_c2
(Table 2). These Q15results suggest involvement of invA, hilD, hilA
and fimA in the progressive loss of virulence in the two mutants;
however, tviA, which showed decreased expression, would only be
related to the phenotype of Ty_c2.
Induction of the immune response is compromised
in Salmonella Typhi mutants
The levels of the proinflammatory cytokines TNF-a and IL-1b
produced by infected U-937 macrophages were measured.
Levels of TNF-a were checked in the supernatants collected
after 2 h of infection and revealed a gradual and significant
decrease in the two mutants compared with Ty_wt. The levels
of this cytokine consisted of 5181 pg/mL in Ty_wt, almost
4000 pg/mL in Ty_c1 and 3256 pg/mL in Ty_c2 (Figure 5a). A
greater reduction was seen for IL-1b, checked in the supernatants
collected at 24 h post-infection: Ty_wt reached 3082 pg/mL
whereas the levels in Ty_c1 and Ty_c2 were reduced by
.50%, showing values of 1167 and 1067 pg/mL, respectively
(Figure 5b).
Since transcription of these two cytokines is controlled by
NF-kB,2,27 activation of this nuclear transcription factor was
checked upon stimulation of HEK293 cells with heat-killed bac-
teria by means of a luciferase reporter assay. Activation of
NF-kB significantly diminished in Ty_c1 compared with the paren-
tal strain and corresponded to a decrease of 16.67%. This Q16ratio
was much more significant for Ty_c2, with a 71% reduction of
the NF-kB activity in comparison with Ty_wt (Figure 5c). The
results obtained in this section indicate that Salmonella Typhi
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Figure 4. Q26Ability to invade HeLa cells and uptake by and survival in
macrophages is compromised upon infection with Ty_c1 and Ty_c2.
Invasion was performed by infecting HeLa cells with the different
bacteria (a). Uptake at 2 h (b) and survival at 24 h (c) was assessed
by infecting human differentiated macrophages with the three
strains studied. Results correspond to the mean of three independent
experiments+standard error. Differences between groups were assessed
using the one-way ANOVA test. *P,0.05.
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mutants elicit a more discrete immunogenic reaction in vitro than
the original clinical isolate, with Ty_c2 being significantly less
reactive.
Discussion
In this study, we evaluated the process of quinolone resistance
acquisition and the impact on virulence properties in the patho-
gen Salmonella Typhi. In the first part of the study, we character-
ized the molecular mechanisms of resistance since they have not
been extensively studied in this Salmonella serovar. We obtained
two mutants, Ty_c1 and Ty_c2, with increased MICs of ciprofloxa-
cin (1 and 8 mg/L, respectively) selected from a clinical isolate
(ciprofloxacin MIC of 0.5 mg/L). All studies reporting resistance
or decreased susceptibility to ciprofloxacin (MIC .0.25 mg/L) in
Salmonella Typhi associate this phenotype with mutations in the
QRDR of the target genes, particularly in gyrA.37,48 InQ17 this study,
we found that Ty_wt already harboured a GyrA substitution
(S83F), but no additional change in anyof the entire quinolone tar-
get genes was detected in the two mutants. The profile of
increased MICs was different for the two mutants. AQ18 moderate
increase to several unrelated compounds was seen in Ty_c1
whereas more suggestive increases were reported for Ty_c2
affecting all compounds tested and leading to anMDR phenotype.
According to the results obtained from gene expression and
protein analyses, we found that alteration of membrane perme-
ability was seen in Ty_c2 due to a reduction in the production of
OmpF and OmpC. Although this alteration in porin expression has
been previously shown in E. coli and non-Typhi Salmonella,31,49,50
it has not been reported in Salmonella Typhi. More importantly,
this MDR phenotype was primarily associated with hyperproduc-
tion of the major efflux pump AcrAB/TolC. Only few reports, such
as that of Chiou et al.,10 have previously reported increased efflux
(based on the use of an efflux pump inhibitor) among Salmonella
Typhi clinical isolates with resistance or decreased susceptibility
to ciprofloxacin (MICs of 0.12–16 mg/L). Nonetheless, this is the
first time that the efflux pump AcrAB/TolC has been characterized
in this serovar. Our findings together with the data of Chiou et al.10
contrast with the results shown by Baucheron et al.,51 in which no
involvement of efflux mechanisms was seen in a collection of
Salmonella Typhi clinical isolates. It is worth mentioning that
themajority of these strains showedMICs of ciprofloxacin ranging
from 0.125 to 1 mg/L, although a single strain had a higher MIC of
8 mg/L, attributed to the acquisition of two further target gene
mutations. In the study by Chiou et al.,10 clinical isolates for
which increased efflux activity was reported had ciprofloxacin
MICs of .4 mg/L. In our study, Ty_c2 had a ciprofloxacin MIC of
8 mg/L. Therefore, we suggest that selection of increased efflux
is acquired at ciprofloxacin MICs of 4–8 mg/L as a general trend.
To better confirm this hypothesis, characterization of larger collec-
tions of ciprofloxacin-resistant clinical isolates is needed to accur-
ately evaluate the relevance and prevalence of this mechanism.
In an attempt to understand the increased levels of AcrAB/TolC
detected in Ty_c2, we found that this was due to alterations in
the marRAB regulatory region. A deletion of almost the entire
marR gene detected in this mutant likely resulted in the absence
of transcription of the repressor, hence leading to hyperproduc-
tion of MarA. This phenotype, in addition to causing increased
amounts of AcrAB/TolC, would also explain the down-regulation
of the OmpF porin detected in Ty_c2. This is the first demonstra-
tion in Salmonella Typhi of the molecular regulation of this efflux
system, as it has been previously described only in non-typhoidal
Salmonella.13,23,52 In addition, and to the best of our knowledge,
it is also the first description of a marR mutation reported in
S. enterica leading to increased AcrAB/TolC, since most of the
reported mutations are located in ramR17,53 and, less frequently,
in acrR54 and soxRS.19
Surprisingly, the transcription levels of the regulators acrR, soxS
and ramA were repressed in Ty_c2. Additionally, the alternative
efflux pump candidates emrB and acrF, reported to be overex-
pressed in quinolone-resistant Salmonella Typhimurium iso-
lates,40 were also studied and revealed down-regulation only in
this mutant. A similar observation has also been reported by
Kang and Woo,55 where expression levels of efflux pump-related
genes were tested in ciprofloxacin-resistant S. enterica serovar
Istanbul mutants. In all of the mutants, not only soxS, but also
acrF, were down-regulated compared with the parental strain
whereas acrB, ramA and/or marA were overexpressed. Despite
another study conducted in E. coli56 reporting an increase in the
expression of soxS in first-stepmutants selected with tetracycline,
a decrease in the expression levels of this gene was observed in
the most resistant strain. Therefore, the authors suggested that
the SoxS response could be activated at the early stages of anti-
biotic resistance adaptation. Considering this proposal, the
decreased expression levels of soxS observed in Ty_c2 could be
partly explained by this phenomenon. According Q19to all these results,
including the findings reported in the present study, it seems that
overexpression of a particular efflux system such as AcrAB may
also lead to reduced expression of some of these regulators and
alternative transport systems to avoid redundancy in efflux trans-
portation, resulting in a reduction of the energy cost of the bacteria.
Contrary to the scenario reported for Ty_c2, the increased MICs
detected for the intermediate resistantmutant Ty_c1 could not be
attributed to the enhanced expression of AcrAB/TolC. Moreover Q20,
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Figure 5. Salmonella Typhi mutants are less immunogenic than Ty_wt.
Levels of TNF-a (a) and IL-1b (b) were measured in infected macrophages
and activation of NF-kB (c) was assessed in stimulated HEK293 cells. Results
correspond to the mean of three independent experiments+standard
error. Differences between groups were assessed using the one-way
ANOVA test. *P,0.05 and **P,0.01.
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gene expression of acrF and emrB was not affected neither. These
results suggest that unknown TolC-independent mechanisms of
resistancewith reduced impact are likely to be involved in antibiotic
resistance.
In the second part of this work, the association between viru-
lence and quinolone resistance was investigated. This relation has
been studied based on data reporting a rise in the number of
Salmonella Typhi clinical isolates with DCS, considered endemic
in countries such as India,57 but a lower incidence of strains show-
ing high levels of ciprofloxacin resistance. A study conducted in
the UK from 2001 to 2004 reported low incidence (1%–2%) of
ciprofloxacin-resistant Salmonella Typhi isolates (MIC ≥1 mg/L)
in contrast to an increase in the number of strains with DCS
(from 35% in 2001 to 47% in 2004).58 NonethelessQ21 , some cases
reporting high levels of ciprofloxacin in Salmonella Typhi have
already emerged.9,59
Moreover, previous studies conducted in different serovars of S.
enterica have already associated quinolone resistance with a
decreased invasion profile. Wang et al.32 reported a reduction in
the expression of SPI-1 genes, decreased ability to invade epithe-
lial cells and low replication inside macrophages in Salmonella
Typhimurium and Salmonella Choleraesuis resistant mutants.
Similarly, studies conducted with Salmonella Typhimurium and
Salmonella Enteritidis also showed an association between resist-
ance, reduced virulence and impaired expression of SPI-1 genes in
quinolone-resistant mutants.16,31 Consistently with these find-
ings, our results showed that upon acquisition of resistance to qui-
nolones, the two mutants showed a progressively reduced ability
to invade epithelial cells andmacrophages. Moreover, the survival
rate insidemacrophages was also diminished. Regulation of these
virulence determinants has been well established in Salmonella
Typhimurium36 and demonstrated to be mostly homologous in
Salmonella Typhi by Faucher et al.26 They identified that SPI-1
genes were involved in the invasion process when infecting
macrophages. Moreover, Bishop et al.60 showed that Salmonella
Typhi strains lacking invA were 1000-fold less able to invade epi-
thelial cells. Thus, the results of our gene expression analysis
agreed with the phenotype observed, since several SPI-1-related
genes (invA, hilA and hilD) showed a gradual reduction in their
expression levels.
In an attempt to find an explanation for this effect on viru-
lence, several hypotheses should be considered. First, DNA super-
coiling has been proposed to influence the transcription process.61
Thus, acquisition of mutations in DNA gyrase has been considered
to impair regular supercoiling activity and hence modify gene
expression patterns.32 Nonetheless, our results do not support
this as our parental strain already had a mutation in GyrA, but
no other QRDR mutation was acquired in the mutants. Second,
impaired bacterial growth has been described for quinolone-
resistant mutants of Salmonella Typhimurium and Salmonella
Enteritidis.31,46,62 This reduced ability to grow may shut off dis-
pensable bacterial functions such as virulence properties.
Nonetheless, the three strains reported in this study did not
show any difference in terms of bacterial growth. On the contrary,
a recent study performed in Salmonella Typhi associated muta-
tions in the QRDR of the target genes with fitness benefits, with
the S83F mutation in GyrA, which leads to DCS, being the most
advantageous.63 The presence of this mutation in our strains
may explain the unchanged growth observed. Third, high produc-
tion levels of AcrAB/TolC have been suggested to be the reason for
impaired virulence.46 As quorum-sensing signal molecules have
been shown to be extruded by efflux pumps64 and suchmolecules
can activate virulence genes,65 an impaired quorum-sensing
homeostasis triggered by increased efflux activity may lead to
impaired gene transcription. To strengthen this hypothesis, a
study conducted by Bailey et al.66 showed that high overexpres-
sion of ramA was accompanied by overexpression of efflux
pumps as well as a decrease in the expression of virulence
genes and impaired host–pathogen interactions. Taking into
account these findings, we suggest that a similar situation
could be happening in the present work triggered by the high over-
expression of marA (.100-fold) in the Ty_c2 mutant.
Additional virulence genes were also studied in the present
work. On the one hand, Salmonella Typhimurium and Salmonella
Typhi have been demonstrated to share a number of pathogen-
esis determinants, such as the bacterial flagellum. Mutations in
the flagellar regulatory genes flhDC and fliA have been associated
with severely decreased entry into eukaryotic cells and reduced
cytotoxicity in macrophages.67 Moreover, uptake and survival
defects in macrophages have also been seen in fliC and flhCD
mutants as reported by Sabbagh et al.68 A correlation between
reduced motility, diminished fliC levels and impaired invasion of
epithelial cells was seen in our mutants. On the other hand,
Salmonella Typhi-specific virulence genes have also been identi-
fied. Among these factors, the most relevant are the genes
located in the Salmonella Typhi-specific pathogenicity island
SPI-7.25,69 The Vi capsular polysaccharide is encoded by the viaB
locus, from SPI-7, and has been reported to be necessary for
Salmonella Typhi survival in macrophages, serum resistance
and systemic dissemination.25,70 An important repression of
the tviA gene was reported in the MDR mutant Ty_c2. Thus, it
seems reasonable that repression of these virulence factors
(FliC and TviA) has also contributed to the impaired virulence
phenotype observed in the two mutants, concerning invasion
of epithelial cells as well as uptake by and survival inside
human macrophages.
It has been previously shown that TviA represses important
virulence factors including genes encoding flagella and T3SS-1
through the flhDC–fliZ–hilD–hilA axis.60,71 In Q22our study, transcrip-
tion of tviA was only repressed in Ty_c2 whereas the expression
levels of fliCand the SPI-1 encoded genes, were already decreased
in the Ty_c1mutant. Thus, these results support the existence of a
tviA-independent regulation of flagellin expression, in accordance
with the representative number of regulators governing flagella
expression reported in other Salmonella serovars. However Q23, we
should not underestimate the role of TviA in this pattern of down-
regulation of fliC and the SPI-1 encoded genes in the Ty_c2
mutant to link the changes observed in these sets of genes.
In the last part of this work, we evaluated the ability of the
mutants to trigger an immunogenic response when infecting
human macrophages. The flagellin protein FliC has been reported
to activate TLR-5 insidemacrophages, thus decreasing the signal-
ling pathway of NF-kB, which elicits cytokine production (TNF-a
and IL-1b). Our results showed that Ty_c1 and Ty_c2 triggered a
poor innate immune response as reflected by a decrease in the
production of these two proinflammatory cytokines as well as in
the nuclear transcriptional regulator NF-kB. This attenuated
immunogenic profile is most likely linked to reduced levels of
FliC, as described previously.72,73 Moreover Q24, we attribute the
more noticeable reduction observed for IL-1b (.2-fold reduction
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compared with TNF-a) to the additive effects of the previously
reported effects and alternative TLR-independent secretion path-
way of IL-1b through caspase-1 activation, which is also stimu-
lated by flagellin.30
Conclusions
The results obtained in the present study provide evidence, for the
first time in Salmonella Typhi, of a link between the MDR pheno-
type and increased levels of AcrAB/TolC caused by the hyperpro-
duction of its regulator MarA. Moreover, we determined that
when Salmonella Typhi acquires resistance to quinolones and
other unrelated antibiotics it becomes less virulent. Concerning
the hypothesis to explain this impaired virulence and host–patho-
gen interactions, our results rule out previously reported explana-
tions such as acquisition of QRDR mutations or reduced growth.
Our findings, particularly those obtained from Ty_c2, reinforce
the idea that high efflux pump activity may affect quorum-
sensing homeostasis, eventually leading to changes in virulence
gene expression. Although more research is needed to clarify
this phenomenon and consider also the situation reported for
Ty_c1, our results contribute to the complex understanding of
quinolone resistance and virulence. On the other hand, with the
aim to explain the lower prevalence of ciprofloxacin-resistant
Salmonella Typhi causing illness in the clinical setting, we
hypothesize that, in comparison with susceptible bacteria, when
quinolone-resistant Salmonella Typhi reaches the gut only a
small proportion of the bacterial load is able to cross the mucosa
and survive inside the host due to: (i) poor invasion of enterocytes
due to a mild activation of the invasion machinery; (ii) reduced
phagocytosis by dendritic cells and macrophages; and (iii)
reduced survival rate insidemacrophages. This situation, together
with decreased activation of the innate immune response, may
result in impaired dissemination of the resistant pathogen.
However, the emergence of isolates able to overcome antibiotic
pressure needs to be taken into account and efforts should be
made to fight against them. InQ25 order to do so, the use of this atte-
nuated strain able to trigger a poor, but still immunogenic,
response as a potential vaccine needs to be considered and fur-
ther explored.
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